US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Viatrexx-Connectissue

Reason Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

8046255 Canada Inc. DBA Viatrexx NDC 73069-100-41 D-0326-2020
Class III · Low risk Terminated

Levetiracetam Injection

Reason Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached.

X-Gen Pharmaceuticals Inc. NDC 39822-4000-1 D-0519-2020
Class II · Moderate risk Terminated

del Nido Cardioplegia Solution

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0151-2020
Class II · Moderate risk Terminated

Amino Acid Injection 50 g/1000 mL

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0150-2020
Class II · Moderate risk Terminated

PF-Fentanyl Citrate

Reason GMP Deviations: potential glass contamination

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk Terminated

Leucovorin Calcium Injection

Reason Crystallization: Presence of particulate matter identified as API crystallization

Ingenus Pharmaceuticals Llc NDC 50742-464-50 D-0146-2020
Class II · Moderate risk Terminated

Rifampin for Injection

Reason Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020
Class III · Low risk Terminated

Motion Sickness Strips

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 69842-288-01 D-0325-2020
Class III · Low risk Terminated

Wal-Dram 2

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 0363-1407-01 D-0324-2020
Class III · Low risk Terminated

Motion Sickness

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 59779-534-01 D-0323-2020
Class III · Low risk Terminated

Zentrip

Reason Subpotent Drug

Sato Pharmaceutical Inc. NDC 49873-803-01 D-0322-2020
Class III · Low risk Terminated

Sankaijo BOTANICAL LAXATIVE

Reason Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.

Sato Pharmaceutical Inc. NDC 49873-404-01 D-0303-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 67091-321-04 D-0302-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-1 D-0301-2020
Class II · Moderate risk Terminated

Children's Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-2130-8 D-0300-2020
Class II · Moderate risk Terminated

Ibuprofen Oral Suspension USP

Reason Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020